EICHORCondition: Inflammatory Joint Diseases · Sponsor: Diakonhjemmet Hospital
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
NOR-DMARD is a register-based longitudinal observational study of which the main objectives are to study the effectiveness of treatment of inflammatory joint diseases with biological disease modifying anti-rheumatic drugs (DMARDs) in clinical practice, by measuring disease activity, health related quality of life, function and joint damage, and to study the long-term safety of such treatment. Other objectives include the assessment of cost-effectiveness of treatment, to identify and and validate clinical, genetic and immunological predictors of efficacy and adverse events, to assess the impact of treatment with biological DMARDs on work participation and work productivity, to investigate different strategies for use of biological DMARDs, to assess the performance of different outcome measures, and to ensure a systematic and timely follow-up of patients treated with biological DMARDs.
This description comes directly from the study's public registry record.
Eirik K Kristianslund, MD, PhD · eirik.kristianslund@gmail.com
Espen A Haavardsholm, MD, PhD · +4722454086 · e.a.haavardsholm@medisin.uio.no
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Age \>18 years * Diagnosis of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, spondyloarthritis, adult juvenile idiopathic arthritis, undifferentiated arthritis, or any other inflammatory arthritis * Clinical indication to start a new treatment with a biological disease modifying anti-rheumatic drug or a kinase inhibitor Exclusion Criteria: * Unwillingness or unability to give written informed consent * Psychiatric or mental disorders, alcohol abuse or other abuse of substances, language barriers or other factors which makes adherence to the study protocol impossible * Participation in blinded RCTs or other studies incompatible with the NOR-DMARD study protocol
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Vestre Viken HF Drammen Hospital | Drammen, Buskerud, Norway | Completed |
| Lillehammer Hospital for Rheumatic Diseases | Lillehammer, Oppland, Norway | Recruiting |
| Førde Hospital | Førde, Sogn Og Fjordane, Norway | Recruiting |
| St. Olavs Hospital | Trondheim, Sør-Trøndelag, Norway | Completed |
| University Hospital of Northern Norway | Tromsø, Troms, Norway | Recruiting |
| Diakonhjemmet Hospital | Oslo, Norway | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01581294